Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Herb: 9Ingredient: 1Target: 2Links: 11
Arranging relationship network...
Record Fields
Scalar fields from the final ingredient record.
- Ingredient Id
- 10421
- Core Entity Id
- 14745
- Source Entity Count
- 1
- Preferred Name
- Alpha-onocerin
- Name En
- Pubchem Id
- 11453544
- Smiles Canonical
- CC1(C2CCC(=C)C(C2(CCC1O)C)CCC3C(=C)CCC4C3(CCC(C4(C)C)O)C)C
- Molecular Formula
- C30H50O2
- Molecular Weight
- 442.7280
- Inchikey
- GESZMTVZGWZBPW-IHIDZKKCSA-N
- Inchi
- InChI=1S/C30H50O2/c1-19-9-13-23-27(3,4)25(31)15-17-29(23,7)21(19)11-12-22-20(2)10-14-24-28(5,6)26(32)16-18-30(22,24)8/h21-26,31-32H,1-2,9-18H2,3-8H3/t21-,22-,23-,24-,25-,26-,29+,30+/m0/s1
- Isomeric Smiles
- C[C@]12CC[C@@H](C([C@@H]1CCC(=C)[C@@H]2CC[C@H]3C(=C)CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)(C)C)O
- Cas Id
- Ob Score
- 39.3088
- Mol Logp
- 7.3058
- Num H Donors
- 2
- Num H Acceptors
- 2
- Num Rotatable Bonds
- 3
- Drug Likeness
- 0.4500
- Polar Surface Area
- Molecular Volume
- Alogp
Names
Preferred names, aliases, and source labels retained in the final schema.
Name
Alpha-Onocerin
Role
preferred
Source
SymMap_v2
Preferred
Yes
Name
Alpha-onocerin
Role
preferred
Source
itcmdb_public
Preferred
Yes
Name
Alpha-onocerin
Role
preferred
Source
HERB_v2
Preferred
Yes
Name
alpha-Onocerin
Role
preferred
Source
ETCM_v2
Preferred
Yes
Name
alpha-onocerin
Role
preferred
Source
TCMBank
Preferred
Yes
Name
(+)-Onocerin
Role
alias
Source
itcmdb_public
Preferred
No
Name
(+)-Onocerin
Role
alias
Source
HERB_v2
Preferred
No
Name
(+)-alpha-onocerin
Role
alias
Source
itcmdb_public
Preferred
No
Name
(+)-alpha-onocerin
Role
alias
Source
HERB_v2
Preferred
No
Name
(2S,4AR,5S,8AR)-5-{2-[(1S,4AR,6S,8AR)-6-HYDROXY-5,5,8A-TRIMETHYL-2-METHYLIDENE-HEXAHYDRO-1H-NAPHTHALEN-1-YL]ETHYL}-1,1,4A-TRIMETHYL-6-METHYLIDENE-HEXAHYDRO-2H-NAPHTHALEN-2-OL
Role
alias
Source
TCMBank
Preferred
No
Name
(2S,4aR,5S,8aR)-5-[2-[(1S,4aR,6S,8aR)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethyl]-1,1,4a-trimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalen-2-ol
Role
alias
Source
itcmdb_public
Preferred
No
Name
(2S,4aR,5S,8aR)-5-[2-[(1S,4aR,6S,8aR)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethyl]-1,1,4a-trimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalen-2-ol
Role
alias
Source
HERB_v2
Preferred
No
Name
(2S,4aR,5S,8aR)-5-{2-[(1S,4aR,6S,8aR)-6-hydroxy-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl]ethyl}-1,1,4a-trimethyl-6-methylenedecahydronaphthalen-2-ol
Role
alias
Source
TCMBank
Preferred
No
Name
(3beta,21alpha)-8,14-Secogammacera-8(26),14(27)-diene-3,21-diol
Role
alias
Source
TCMBank
Preferred
No
Name
(3beta,21alpha)-8,14-Secogammacera-8(26),14(27)-diene-3,21-diol
Role
alias
Source
itcmdb_public
Preferred
No
Name
(3beta,21alpha)-8,14-Secogammacera-8(26),14(27)-diene-3,21-diol
Role
alias
Source
HERB_v2
Preferred
No
Name
2-Naphthalenol,5,5'-(1,2-ethanediyl)bis[decahydro-1,1,4a-trimethyl-6-methylene-,(2S,2'S,4aR,4'aR,5S,5'S,8aR,8'aR)-
Role
alias
Source
TCMBank
Preferred
No
Name
511-01-3
Role
alias
Source
TCMBank
Preferred
No
Name
511-01-3
Role
alias
Source
HERB_v2
Preferred
No
Name
511-01-3
Role
alias
Source
itcmdb_public
Preferred
No
Name
8,14-secogammacera-8(26),14(27)-diene-3beta,21alpha-diol
Role
alias
Source
HERB_v2
Preferred
No
Name
8,14-secogammacera-8(26),14(27)-diene-3beta,21alpha-diol
Role
alias
Source
TCMBank
Preferred
No
Name
8,14-secogammacera-8(26),14(27)-diene-3beta,21alpha-diol
Role
alias
Source
itcmdb_public
Preferred
No
Name
Alpha-onocerin chloroform hemisolvate
Role
alias
Source
itcmdb_public
Preferred
No
Name
Alpha-onocerin chloroform hemisolvate
Role
alias
Source
HERB_v2
Preferred
No
Name
Alpha-onocerin, primary pharmaceutical reference standard
Role
alias
Source
TCMBank
Preferred
No
Name
C21734
Role
alias
Source
TCMBank
Preferred
No
Name
CHEBI:138303
Role
alias
Source
TCMBank
Preferred
No
Name
EINECS 208-118-6
Role
alias
Source
TCMBank
Preferred
No
Name
EINECS 208-118-6
Role
alias
Source
itcmdb_public
Preferred
No
Name
EINECS 208-118-6
Role
alias
Source
HERB_v2
Preferred
No
Name
GESZMTVZGWZBPW-IHIDZKKCSA-
Role
alias
Source
TCMBank
Preferred
No
Name
InChI=1/C30H50O2/c1-19-9-13-23-27(3,4)25(31)15-17-29(23,7)21(19)11-12-22-20(2)10-14-24-28(5,6)26(32)16-18-30(22,24)8/h21-26,31-32H,1-2,9-18H2,3-8H3/t21-,22-,23-,24-,25-,26-,29+,30+/m0/s1
Role
alias
Source
TCMBank
Preferred
No
Name
MCULE-4277793393
Role
alias
Source
TCMBank
Preferred
No
Name
MolPort-006-111-540
Role
alias
Source
TCMBank
Preferred
No
Name
SC-97924
Role
alias
Source
TCMBank
Preferred
No
Name
W2391
Role
alias
Source
TCMBank
Preferred
No
Name
ZINC38605938
Role
alias
Source
TCMBank
Preferred
No
Name
alpha-Onocerin
Role
alias
Source
TCMBank
Preferred
No
Name
alpha-Onocerol
Role
alias
Source
TCMBank
Preferred
No
Name
alpha-Onocerol
Role
alias
Source
HERB_v2
Preferred
No
Name
alpha-Onocerol
Role
alias
Source
itcmdb_public
Preferred
No
Name
α-onocerin
Role
alias
Source
TCMBank
Preferred
No
Aliases
Additional names normalized into the restored final schema.
(+)-Onocerin(+)-alpha-onocerin(2S,4AR,5S,8AR)-5-{2-[(1S,4AR,6S,8AR)-6-HYDROXY-5,5,8A-TRIMETHYL-2-METHYLIDENE-HEXAHYDRO-1H-NAPHTHALEN-1-YL]ETHYL}-1,1,4A-TRIMETHYL-6-METHYLIDENE-HEXAHYDRO-2H-NAPHTHALEN-2-OL(2S,4aR,5S,8aR)-5-[2-[(1S,4aR,6S,8aR)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethyl]-1,1,4a-trimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalen-2-ol(2S,4aR,5S,8aR)-5-{2-[(1S,4aR,6S,8aR)-6-hydroxy-5,5,8a-trimethyl-2-methylenedecahydronaphthalen-1-yl]ethyl}-1,1,4a-trimethyl-6-methylenedecahydronaphthalen-2-ol(3beta,21alpha)-8,14-Secogammacera-8(26),14(27)-diene-3,21-diol2-Naphthalenol,5,5'-(1,2-ethanediyl)bis[decahydro-1,1,4a-trimethyl-6-methylene-,(2S,2'S,4aR,4'aR,5S,5'S,8aR,8'aR)-511-01-38,14-secogammacera-8(26),14(27)-diene-3beta,21alpha-diolAlpha-onocerin chloroform hemisolvateAlpha-onocerin, primary pharmaceutical reference standardC21734CHEBI:138303EINECS 208-118-6GESZMTVZGWZBPW-IHIDZKKCSA-InChI=1/C30H50O2/c1-19-9-13-23-27(3,4)25(31)15-17-29(23,7)21(19)11-12-22-20(2)10-14-24-28(5,6)26(32)16-18-30(22,24)8/h21-26,31-32H,1-2,9-18H2,3-8H3/t21-,22-,23-,24-,25-,26-,29+,30+/m0/s1MCULE-4277793393MolPort-006-111-540SC-97924W2391ZINC38605938alpha-Onocerolα-onocerin
Cross References
Trusted external identifiers retained for this final record.
Cas
511-01-3
Herb
HBIN015629
Npass
NPC145952
Tcmid
1610724265
Tcmsp
MOL005421
Sym Map
SMIT02065SMIT07182
Tcm Id
6895
Pub Chem
11453544
Tcmbank
TCMBANKIN018728
Etcm Ingredient
alpha-Onocerin
Itcmdb Generated
ITX-INGREDIENT-993C8D166A44
Attributes
Merged source attributes and domain-specific metadata.
In Ch I
InChI=1S/C30H50O2/c1-19-9-13-23-27(3,4)25(31)15-17-29(23,7)21(19)11-12-22-20(2)10-14-24-28(5,6)26(32)16-18-30(22,24)8/h21-26,31-32H,1-2,9-18H2,3-8H3/t21-,22-,23-,24-,25-,26-,29+,30+/m0/s1
Mol Wt
442.7280000000002
Smiles
CC1(C2CCC(=C)C(C2(CCC1O)C)CCC3C(=C)CCC4C3(CCC(C4(C)C)O)C)C
Mol Log P
7.305800000000011
Version
v1,v2
In Ch Ikey
GESZMTVZGWZBPW-IHIDZKKCSA-N
Ob Score
39.30881936
Suppress
1
Num Hdonors
2
Drug Likeness
0.45
Num Hacceptors
2
Isomeric Smiles
C[C@]12CC[C@@H](C([C@@H]1CCC(=C)[C@@H]2CC[C@H]3C(=C)CC[C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)(C)C)O
Molecule Weight
442.8
Canonical Smiles
CC1(C2CCC(=C)C(C2(CCC1O)C)CCC3C(=C)CCC4C3(CCC(C4(C)C)O)C)C
Herb Alias Names
511-01-3alpha-OnocerolEINECS 208-118-6(3beta,21alpha)-8,14-Secogammacera-8(26),14(27)-diene-3,21-diolAlpha-onocerin chloroform hemisolvate8,14-secogammacera-8(26),14(27)-diene-3beta,21alpha-diol(2S,4aR,5S,8aR)-5-[2-[(1S,4aR,6S,8aR)-6-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl]ethyl]-1,1,4a-trimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalen-2-ol(+)-alpha-onocerin(+)-Onocerin-Onocerin
Molecular Weight
442.380
Molecular Weight
442.7 g/mol
Molecule Formula
C30H50O2
Molecular Formula
C30H50O2
Molecular Formula
C30H50O2
Molecular Formula
C30H50O2
Num Rotatable Bonds
3
Link Ingredient Id
2065.0
Fda Maximum Daily Dose (Fdamdd)
0.996
Quantitative Estimate Of Drug Likeness(Qed)
0.450